Walleye Capital
GMED icon

Walleye Capital’s Globus Medical GMED Stock Holding History

Walleye Capital’s Portfolio GMED Stock Details GMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.42M Buy
16,500
+11,800
+251% +$1.06M 0.01% 1758
2025
Q4 		$410K Buy
+4,700
New +$357K ﹤0.01% 3076
2025
Q1 		– Sell
-1,000
Closed -$82.7K – 4564
2024
Q4 		$82.7K Hold
1,000
– – ﹤0.01% 4210
2024
Q3 		$71.5K Sell
1,000
-13,600
-93% -$960K ﹤0.01% 4528
2024
Q2 		$1,000K Buy
+14,600
New +$872K ﹤0.01% 2851
2024
Q1 		– Sell
-3,200
Closed -$171K – 5571
2023
Q4 		$171K Buy
+3,200
New +$156K ﹤0.01% 3767

Other funds holding GMED

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
SC
Sculptor Capital New York $9.61B AUM 27.49% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Bank of Montreal
Bank of Montreal Toronto, Ontario, Canada $269B AUM 31.4% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Walleye Capital's GMED Position: Q1 2026 in Review

Walleye Capital reduced its Globus Medical (GMED) stake by 100% in Q1 2026, selling an estimated $73.5M and leaving 27 shares worth $2.33K. The position accounts for ﹤0.01% of the portfolio, ranked #4230.

Walleye Capital first reported a position in GMED in Q4 2020 and has held it in 22 quarters since. The position peaked at $71.5M in Q4 2025. 602 funds tracked by Wall St. Rank hold GMED as of Q1 2026.

  • Walleye Capital held 27 shares of Globus Medical worth $2.33K as of Q1 2026.
  • Walleye Capital sold 818,829 Globus Medical shares in Q1 2026, an estimated $73.5M.
  • Globus Medical made up ﹤0.01% of Walleye Capital's portfolio in Q1 2026, its #4230 holding.
  • Walleye Capital first reported a position in Globus Medical in Q4 2020 and has held it in 22 quarters since.
  • Walleye Capital's Globus Medical position peaked at $71.5M in Q4 2025.
  • 602 funds tracked by Wall St. Rank held Globus Medical as of Q1 2026.

Based on Walleye Capital's 13F filing for Q1 2026, filed 11 May 2026.